Organization
National Cancer Center Hospital East
5 clinical trials
Clinical trial
Phase 2 Study of Nivolumab Plus Lenvatinib for Patients With Unresectable Anaplastic Thyroid Cancer (NAVIGATION Study)Status: Active (not recruiting), Estimated PCD: 2025-07-01
Clinical trial
Phase II Study of Darolutamide (ODM-201) in Patients With Androgen Receptor-positive Salivary Gland Carcinoma (Discovary Study)Status: Active (not recruiting), Estimated PCD: 2024-08-01
Clinical trial
A Phase Ib/II Study of Regorafenib and Nivolumab Plus Chemotherapy in Patients With Unresectable Advanced/Recurrent Gastric/Gastroesophageal Junction/Esophageal AdenocarcinomaStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
A Pilot Study to Evaluate the Efficacy and Safety of Preoperative Olaparib Monotherapy and Preoperative Olaparib Plus Pembrolizumab Combination Therapy in Patients With HRD-Positive Stage III or IV Advanced Epithelial Ovarian/Fallopian Tube/Primary Peritoneal CancerStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
A Multicenter Randomized Phase III Study of Short-term Radiotherapy Plus CAPOX and Short-term Radiotherapy Plus CAPOXIRI as Preoperative Treatment for Locally Advanced Rectal CancerStatus: Recruiting, Estimated PCD: 2029-12-31